ClinicalTrials.gg
RecruitingNCT07946510Updated Nov 18, 2026

Mini-RISK in Agder: A Cluster Randomized Controlled Trial of a Low-Threshold School-Based Program for Anxious Students Delivered by School Personnel in the School Setting

An interventional study of Mini-RISK School-based group CBT and Usual School Nurse Support in Anxiety, sponsored by Sorlandet Hospital HF. Recruiting at 1 site in Norway. Open to participants aged 10 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Sorlandet Hospital HF · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
640
Allocation
Randomized
Ages
10 Years to 16 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if Mini-RISK, a short group program at school, reduces anxiety in young people aged 12 to 16 more than the usual help they get from the school nurse.

The main question it aims to answer is:

Does Mini-RISK lower anxiety symptoms more than usual school nurse support, measured 8 weeks after the start?

Other questions are:

Does Mini-RISK improve quality of life, school attendance and school functioning? Does Mini-RISK reduce the ways families and schools help young people avoid what they fear (called accommodation)? Which young people benefit most, for example depending on how they handle uncertainty, how their family functions, bullying, and social media use?

About 70 schools in 10 municipalities in Agder, Norway, were assigned by chance (like drawing lots) to offer either Mini-RISK or usual school nurse support. Young people who seek help for anxiety at school get the help their school offers. Researchers will compare the two groups to see if Mini-RISK works better than usual support.

In Mini-RISK, groups of 4 to 6 young people meet at school for 8 sessions over 8 weeks (about 15.5 hours in total). The groups are led by a school nurse and a school social teacher who have been trained in the program. Parents take part in 4 sessions and contact teachers in 2. Young people learn about anxiety and practice, step by step, facing situations they fear, with support from parents and teachers.

Usual support means individual follow-up from the school nurse, such as supportive conversations, adjustments at school and referral to other services when needed.

Participants and their parents will:

Fill out online questionnaires at the start, after 8 weeks, after 22 weeks and after 12 months (about 15 to 20 minutes each time) Answer a short questionnaire (about 5 minutes) each week during the 8-week program period

After the randomized part of the study, schools that offered usual support will also be trained in Mini-RISK, and data from these schools will be used to study who benefits most from the program.

Read the detailed description

Background. Anxiety disorders affect 6 to 15% of young people and often impair school functioning, attendance and quality of life. Cognitive behavioral therapy (CBT) with exposure is the best documented treatment, but it is rarely available to anxious youth outside specialist services. In Norwegian schools, the most common help is supportive counseling by the school nurse, which has no documented effect. Schools also often accommodate anxiety, for example by exempting students from feared activities, which may maintain anxiety over time. Mini-RISK is a brief, school-based CBT group program developed at the Department of Child and Adolescent Mental Health, Sørlandet Hospital, as a low-threshold version of the RISK multi-family exposure program. It is delivered jointly by school health and school personnel, with active involvement of parents and contact teachers, and targets exposure and the reduction of family and school accommodation. Mini-RISK has been implemented in all 42 schools in Kristiansand municipality but has not been tested in a randomized trial.

Design. Cluster randomized controlled trial with schools as the unit of randomization. About 70 schools in 10 municipalities in Agder, Norway, were randomized in October 2025 to receive Mini-RISK training first (intervention) or to continue usual practice (business as usual, BAU) during the randomized phase. Randomization was stratified by school size and socioeconomic characteristics of the school district and performed in R by a member of the research team. Students receive the help offered at their school, and the trial follows the existing ways schools handle students who seek help.

Training and delivery. In Mini-RISK schools, two staff members, preferably a school nurse and a school social teacher, complete a 15-credit continuing education program at the University of Agder: 8 days of teaching and 23 hours of video-based supervision over one year, given by experienced RISK therapists and Mini-RISK group leaders. Local coordinators employed by each municipality support group leaders, recruitment and data collection. Usual support is expected to vary across schools and municipalities and remains the responsibility of each school.

Procedure. Students are recruited when they seek help for anxiety, or are encouraged to seek help, through the school nurse or social teacher, parent meetings and school information channels. A local coordinator assesses eligibility. Written information and consent are distributed through CheckWare, a secure platform approved by Sørlandet Hospital. Students aged 16 consent themselves; for students under 16, guardians consent and the student can decline. In BAU schools, follow-up starts immediately. In Mini-RISK schools, treatment starts when a group has been formed. Participants are encouraged not to seek other anxiety treatment during the intervention period unless clinically needed, and are referred onward if concerns arise. Assessments are completed digitally by youth and parents at baseline, weekly during the intervention period, at 8 weeks (primary endpoint, post-intervention), at 22 weeks and at 12 months.

Blinding. Participants and providers cannot be blinded, and outcomes are self- and parent-reported. Outcome analyses are performed by a statistician who has not been involved in recruitment or contact with participants, and who remains blinded to results until follow-up is complete.

Statistical analysis. Intention-to-treat analyses with multilevel (hierarchical) regression accounting for repeated measures within students and students within schools. Missing data are handled with full-information maximum likelihood. Moderation of effects is tested with interaction terms in the same framework. Session-to-session processes are analyzed with multilevel autoregressive cross-lagged models. Results are reported across all participating schools; no analyses will identify individual schools.

Sample size. The minimal important difference for the primary outcome is Cohen's d = 0.5. With alpha .05, power .80 and 20% missing data, 140 participants per arm are required. Predictor analyses (f² = 0.05) require 334 participants, and session-to-session analyses 180. With about 70 schools each including at least 4 participants per year over two years, about 640 participants are expected.

Open phase. After the randomized phase (2026 to 2028), BAU schools are trained in Mini-RISK, and data collection continues in all schools (2028 to 2030) to study predictors and moderators of outcome. Data from the open phase are not part of the randomized comparison.

Ethics and data. Approved by REK sør-øst A (964909). Data are pseudonymized, stored on a secure research server at Sørlandet Hospital, and handled in line with the GDPR.

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • school-based intervention
  • cognitive behavioral therapy
  • exposure therapy
03

In context

Anxiety Disorders Unverified

7,238 studies on the registry are indexed under Anxiety Disorders; 1,687 are open to participants now.

This study's planned enrollment of 640 is above the median of 80 across 6,092 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Sorlandet Hospital HF is the lead sponsor of 75 studies on the registry; 13 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
10 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 10 to 16 years
  • Attends a participating school in one of the 10 participating municipalities in Agder, Norway
  • Seeks help, or is encouraged by adults to seek help, for anxiety at school
  • Score of 15 or higher on the Spence Children's Anxiety Scale, child version (SCAS-C)
  • Youth and parent(s) proficient in Norwegian
  • Written from both guardians for youth under 16 years (youth may decline participation), or from the youth for those aged 16 years
  • Willing to complete study questionnaires and to accept the intervention offered at their school

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric conditions that would not normally be handled in the school setting (e.g., psychosis, suicidal ideation, self-harm, or anxiety severe enough to require specialist care)
  • Ongoing treatment in, or referral to, specialist mental health services
  • Drug or alcohol dependence
  • Developmental disorders, including autism spectrum disorder, or severe cognitive impairment
  • Known serious somatic disease needing medical treatment or likely to interfere with participation (e.g., cancer, epilepsy, moderate to severe traumatic brain injury)
  • Youth or parents unable to attend scheduled intervention sessions
  • Anxiety is not the main problem for which the youth and family need help (e.g., severe family conflict or dissolution, or ongoing external stressors such as bullying)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
640 participants (estimated)

Study arms

  • Experimental
    Mini-RISK School-based group CBT

    Schools randomized to Mini-RISK. Students receive Mini-RISK, a school-based cognitive behavioral group program for anxiety. Groups of 4 to 6 students meet at school for 8 sessions over 8 weeks (about 15.5 hours), plus a follow-up session after about 3 months. Groups are led by a school nurse and a school social teacher who have completed Mini-RISK training at the University of Agder (8 days of teaching and 23 hours of video-based supervision). Parents attend 4 sessions and contact teachers 2 sessions. Core elements are psychoeducation, graded exposure to feared situations (including two 3-hour group exposure sessions with parents), homework, and reducing unhelpful family and school accommodation of anxiety.

    Behavioral: Mini-RISK School-based group CBT

  • Active comparator
    Usual School Nurse Support

    Schools randomized to business as usual (BAU) during the randomized phase. Students receive the individual support the school nurse normally provides to students who seek help for anxiety. Support is needs-based and may include supportive conversations, assessment of needs, adjustments at school, involvement of parents, and referral to municipal or specialist services when needed. It is not manualized or time-limited and is expected to vary between schools and municipalities. No existing school services are removed or changed. These schools are trained in Mini-RISK after the randomized phase.

    Behavioral: Usual School Nurse Support

Interventions

  • BehavioralMini-RISK School-based group CBT

    Manualized, low-threshold group CBT program for anxious youth, developed at the Department of Child and Adolescent Mental Health, Sørlandet Hospital, as a brief school-based version of the RISK multi-family exposure program. Unlike most CBT programs delivered by health professionals only, Mini-RISK is co-led by school health and school staff (a school nurse and a school social teacher) and actively involves parents and contact teachers. Youth attend sessions 2 to 8, parents sessions 1, 4, 6 and 8, and teachers sessions 1 and 8. Most session time is used for in-session exposure. Parents help each other's children during group exposure, and parents and teachers learn to reduce accommodation and to support exposure at home and at school. Group leaders receive ongoing supervision from experienced RISK therapists and Mini-RISK leaders.

    Also known as: Mini-RISK

  • BehavioralUsual School Nurse Support

    Individual support from the public school nurse as routinely provided in Norwegian schools to students who seek help for anxiety. Content and frequency are determined by the school nurse according to need and may include supportive counseling, needs assessment, school adjustments, contact with parents and teachers, and referral to other services. Not manualized, time-limited or anxiety-specific. Quality assurance is the responsibility of each school and municipality.

    Also known as: Business as usual (BAU)

06

What researchers measure

Primary outcomes

  1. Change in Anxiety Symptoms (Spence Children's Anxiety Scale, Child Version, Total Score)

    Youth-reported anxiety symptoms measured with the Norwegian version of the Spence Children's Anxiety Scale, child version (SCAS-C). The questionnaire has 44 items, of which 38 are scored on a 4-point scale (0 = never to 3 = always); 6 positive filler items are not scored. Total score range 0 to 114; higher scores indicate more severe anxiety. The difference between Mini-RISK and usual school nurse support in change from baseline to 8 weeks will be estimated with multilevel models accounting for clustering of students within schools (intention-to-treat).

    Time frame: Pre-post and Pre-12moFU

  2. Change in Anxiety Symptoms (Spence Children's Anxiety Scale, Parent Version, Total Score)

    Parent-reported anxiety symptoms of the child measured with the Norwegian version of the Spence Children's Anxiety Scale, parent version (SCAS-P). The questionnaire has 38 items scored on a 4-point scale (0 = never to 3 = always). Total score range 0 to 114; higher scores indicate more severe anxiety. The difference between Mini-RISK and usual school nurse support in change from baseline to 8 weeks will be estimated with multilevel models accounting for clustering of students within schools (intention-to-treat).

    Time frame: Pre-post and Pre-12moFU

Secondary outcomes

  1. Change in Health-Related Quality of Life (KIDSCREEN-10 Index)

    KIDSCREEN-10 index, completed separately by youth (self-report) and parent (proxy report). 10 items rated on a 5-point scale, converted to Rasch-based T-scores (mean 50, SD 10); higher scores indicate better health-related quality of life. One additional item on general health is reported descriptively.

    Time frame: Baseline, Post-treatment and 12moFU

  2. Change in School Attendance Problems (Inventory of School Attendance Problems, ISAP / ISAP-P)

    Completed separately by youth (ISAP) and parent (ISAP-P), items SP1 to SP10. Includes frequency of school absence in the last 12 school weeks (6 categories, from no absence to almost all the time), excused versus unexcused absence (visual analogue scale), and difficulty with 8 school-day situations (e.g., getting up, getting to school, entering the classroom) rated from "not at all" to "very much". Higher scores indicate more attendance problems.

    Time frame: Baseline, Post-treatment and 12moFU

  3. Change in Self-Rated School Functioning (Single Item, 0 to 10)

    Single item adapted from the Work Ability Index (Kainulainen et al., 2023), completed separately by youth and parent: current school functioning compared with functioning at its best, rated 0 (cannot function at school at all) to 10 (school functioning at its best). Higher scores indicate better school functioning.

    Time frame: Baseline, Post-treatment and 12moFU

  4. Change in Global Anxiety Severity (Clinical Global Impression-Severity, Adapted for Youth and Parent Report)

    Single item adapted from the Clinical Global Impression scale, completed separately by youth and parent: how much the youth has been troubled by anxiety in the past week, rated 1 (not troubled) to 7 (extremely troubled). Higher scores indicate more severe anxiety.

    Time frame: Baseline, Post-treatment and 12moFU

  5. Change in Family Accommodation of Anxiety (Family Accommodation Scale-Anxiety, FASA)

    Parent-reported family accommodation of the child's anxiety. 13 items; the accommodation score is the sum of items 1 to 9 (participation and modification), each rated 0 (never) to 4 (daily), range 0 to 36. Higher scores indicate more accommodation. Items 1 to 9 are also collected weekly during the intervention period with a past-week time frame.

    Time frame: Baseline, Post-treatment and 12moFU

  6. Change in Depressive Symptoms (Abbreviated Patient Health Questionnaire, 4 Items)

    Four items from the PHQ-9 selected according to Smith et al. (2025), completed separately by youth (self-report) and parent (report on the youth). Items rated 0 (not at all) to 3 (nearly every day); total 0 to 12. Higher scores indicate more depressive symptoms.

    Time frame: Baseline, Post-treatment and 12moFU

  7. Change in Generalized Anxiety Symptoms (Abbreviated Generalized Anxiety Disorder Scale, 3 Items)

    Three items from the GAD-7 selected according to Smith et al. (2025), completed separately by youth and parent. Items rated 0 (not at all) to 3 (nearly every day); total 0 to 9. Higher scores indicate more anxiety symptoms.

    Time frame: Baseline, Post-treatment and 12moFU

  8. Change in Intolerance of Uncertainty (7 Items From the Intolerance of Uncertainty Scale-12)

    Seven items selected from the IUS-12 (Carleton et al., 2007), completed separately by youth (self) and parent (self). Items rated 1 (not at all characteristic of me) to 5 (entirely characteristic of me); total 7 to 35. Higher scores indicate greater intolerance of uncertainty.

    Time frame: Baseline, Post-treatment and 12moFU

  9. Change in Problematic Social Media Use (Bergen Social Media Addiction Scale)

    Youth-reported problematic social media use on the Bergen Social Media Addiction Scale (Andreassen et al., 2016). 6 items rated 1 (very rarely) to 5 (very often); total 6 to 30. Higher scores indicate more problematic use.

    Time frame: Baseline, Post-treatment and 12moFU

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the published results (outcome and baseline variables) will be shared with qualified researchers on reasonable request. Because participants come from small schools and municipalities where indirect identification is possible, data will not be made openly available unless they can be fully anonymized. Sharing requires approval from the Regional Committee for Medical and Health Research Ethics (REK) where applicable, a data processing or data transfer agreement with the responsible institution, and compliance with the GDPR. Aggregated data and analysis code will be made openly available on the Open Science Framework.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: From publication of the primary results until 5 years after the end of the project (31 December 2035), after which data will be deleted or anonymized in line with the REK approval.

Access criteria: Requests from researchers with a methodologically sound proposal, sent to the principal investigator. Access is granted after review by the project group and approval of required ethics and data-protection agreements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2029, 37 months later.

Of 3,866 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 37 months is above that.

Counting every sponsor, half of 3,969 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Dec 24, 2029
CompletionEst.
Dec 24, 2030
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946510
Lead sponsor
Sorlandet Hospital HF
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Dec 24, 2029 (estimated)
Completion
Dec 24, 2030 (estimated)
Last update
Nov 18, 2026

Study contacts

Åshild T. Håland, Professor
Contact
aashild.haaland@sshf.no
+4791523438

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion